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Abstract 
Crohn’s disease (CD) and Takayasu’s arteritis (TA) are inflammatory granulomatous 
autoimmune disorders. Simultaneous occurrence of CD and TA in the same individual is 
rare. We report two cases treated with biologic agents. Case 1: A 16-year-old male 
presented with abdominal pain, nausea, vomiting. CT angiogram showed thickening of 
the terminal ileum, wall thickening and narrowing of multiple large and medium arteries 
including aorta and left common carotid. Colonoscopy with biopsy of the stenotic 
ileocecal valve confirmed CD. Resected carotid artery pathology was consistent with TA. 
Treatment was initially begun with prednisone, then methotrexate was started followed 
by infliximab. Due to side effects, methotrexate was switched to azathioprine. He 
remained asymptomatic. Case 2: A 38-year-old male with well-characterized Crohn’s 
ileocolitis for 15 years, who had been treated with prednisone, mesalamine, 
sulfasalazine, and azathioprine presented with chest, upper back and abdominal pain. CT 
angiogram showed vasculitis of large and medium arteries, with stenosis of the right 
renal artery, and wall thickening of the sigmoid colon. He was diagnosed with TA. He 
underwent treatment with infliximab and adalumimab on different occasions, which 
were later discontinued due to fever, bacteremia and complications from sepsis. He 
remained on prednisone and azathioprine. In these two patients with both CD and TA 
the diagnoses were confirmed by imaging and pathologic findings. Both patients 
developed vascular complications. Tumor necrosis factor inhibitor therapy was effective 
in one patient but discontinued in the other due to infection. Further research into the 
association of CD and TA may provide clues to their etiologies and guide effective 
interventions. 
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Introduction 
Takayasu’s arteritis (TA) and Crohn’s disease (CD) are chronic inflammatory 
granulomatous autoimmune disorders that lead to characteristic manifestations. The 
exact etiologies of these diseases remain unknown. CD predominantly affects the 
gastrointestinal tract, and various hypotheses concerning the underlying pathology have 
been proposed, ranging from environmental [1], genetic [2], infections [3], autoimmune 
processes [4] to a defect in autophagy [5]. CD appears to be more prevalent in Caucasian 
populations, but recent reports have shown a rising incidence in Asian populations [6]. 
TA is a large vessel vasculitis predominantly affecting the aorta and its main branches. It 
usually presents in young adults. The chronic inflammation of unknown etiology 
affecting the arteries may lead to stenosis, occlusions, dilatations and aneurysms of 
affected vessels [7]. Cell-mediated autoimmunity leading to granulomatous inflammation 
is believed to represent the most probable pathologic cause of the disease. TA is more 
prevalent in Asia than in Western countries [8]. Simultaneous occurrence of these two 
diseases in the same individual is rare. We report two new cases seen in our institution. 
Case 1 
A 16-year-old male with a past medical history of thalassemia trait and recent diagnosis of 
hypertension presented with complaints of abdominal pain, nausea, vomiting, constipation and weight 
loss. He did not have any diarrhea, hematochezia or melena. The work-up for abdominal pain 
prompted CT angiogram imaging that revealed marked thickening of the terminal ileum and decreased 
uptake and atrophy of the left kidney, significant wall thickening and narrowing of the left common 
carotid, right common and internal carotid and subclavian and axillary arteries, and diffuse thickening 
of aortic arch and descending thoracic and upper abdominal aorta, with left renal artery occlusion 
(fig. 1). ESR and CRP were elevated. An MR enterography of the abdomen confirmed the mucosal 
thickening of the terminal ileum without bowel wall edema or additional sites of stenosis, 
hyperenhancement or fistulas. A colonoscopy was performed which revealed stenotic ileocecal valve 
with friable and inflamed terminal ileal mucosa and an ulceration (fig. 2). Biopsy from the terminal 
ileum confirmed the diagnosis of CD showing moderate active chronic ileitis. His laboratory studies 
were significant for elevated sedimentation rate of 23 and CRP of 27, positive antiflagellin antibody 
(CBir1), but negative antisaccharomyces antibody (ASCA), outer membrane porin to Escherichia coli 
antibody (anti OmpC), lupus anticoagulant and anticardiolipin antibodies. 
Prednisone 60 mg daily was started. Meanwhile, he developed retinal and cerebral ischemic episodes, 
leading to transient visual loss and syncope, for which he underwent ascending aorta to left common 
carotid artery bypass grafting. The resected carotid artery pathology was consistent with TA. 
Methotrexate was added. He did not have any significant relapse or symptoms of active CD other than 
intermittent abdominal pain. However, he suffered another episode of syncope with dehydration 
leading to thrombotic occlusion of his aortocarotid bypass graft requiring thrombectomy and revision 
of the graft. Infliximab was started to intensify his therapy. Methotrexate was later discontinued due to 
side effects and azathioprine was started instead. Prednisone was gradually tapered off. He remained 
asymptomatic as both his CD and TA remained under good control for twelve months. 
Case 2 
A 38-year-old male with a past medical history of hypertension and mild renal insufficiency 
presented with abdominal pain, diarrhea and chest pain. CD had been diagnosed 15 years prior to 
presenting to our institution by means of colonoscopy with biopsy. Review of reports from prior 
examinations revealed that CD was initially active in the colon, but later involved the small intestine as 
well. There was no previous history of strictures or fistulas or such findings during further evaluation in 
our institution. During the past 15 years he had been treated with prednisone, mesalamine, sulfasalazine 
and azathioprine. He had been on infliximab for 1 year when he developed chest, upper back and 
abdominal pain and noted to have ectasia of the descending aorta. Infliximab was discontinued 
6 months later due to fever, bacteremia, and acute renal failure. He had remained on prednisone and  
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azathioprine chronically. The CD appeared to be inactive, except for episodic diarrhea without any 
hematochezia. 
His abdominal imaging revealed thickening and paraaortic stranding of the abdominal aorta and 
wall thickening of the sigmoid colon, but also bilateral renal artery stenosis, which prompted further 
imaging of the chest and neck. TA was diagnosed when the CT angiogram showed wall thickening of 
the aortic arch, abdominal aorta, left subclavian and common carotid arteries, with sigmoid colon wall 
thickening (fig. 3). His laboratory studies were remarkable for leukocytosis, elevated CRP and normal 
sedimentation rate, but negative antinuclear antibody (ANA), p-ANCA (antinuclear cytoplasmic 
antibody), antiflagellin antibody (Cbir1), antisaccharomyces antibody (ASCA), outer membrane porin 
to Escherichia coli antibody (antiOmpC), hepatitis A, B and C serologies. When follow-up imaging 
showed severe bilateral renal artery stenoses and renal atrophy, an aorto-birenal bypass grafting was 
performed. Adalimumab was started 6 months later due to persistent inflammation and elevated ESR 
and CRP despite prednisone and azathioprine therapy. Three weeks later he sustained sepsis, 
thrombosis of the graft, and renal failure requiring dialysis. Adalimumab was discontinued. He 
remained on prednisone and azathioprine thereafter and has remained stable for eight months. 
Discussion 
CD, being an inflammatory bowel disease, is associated with extraintestinal 
manifestations and other autoimmune disorders with a higher prevalence than ulcerative 
colitis [9]. Vasculitis, predominantly of the mesenteric vessels, has been suggested as a 
possible etiologic cause for intestinal manifestations, leading to ischemic damage and 
multifocal infarctions of the bowel wall, although granulomatous inflammation of the 
bowel wall generally does not correspond to the site of vasculitis [10]. Increased 
thrombophilia associated with inflammatory bowel disease can lead to regional or 
systemic complications of infarctions, thrombosis and embolism. 
TA is a chronic idiopathic large vessel vasculitis of the aorta and/or its branches. 
Histopathological diagnosis of TA is difficult due to the involvement of major blood 
vessels. Hence imaging modalities like angiography, CT and MRI are being increasingly 
used as diagnostic techniques for TA [11]. Pathology of a resected artery was helpful in 
one of our patients, while the imaging studies were the main modes of diagnosis in both 
patients.  
Simultaneous occurrence of these two diseases in the same individual is rare, but is 
being increasingly reported in part owing to heightened awareness and better access to 
superior diagnostic imaging. Similarities in the presentation of abdominal symptoms, 
especially abdominal pain [12] and gastrointestinal bleeding in both these diseases might 
delay or confound the diagnosis of one or the other. Granulomatous vasculitis due to 
cell-mediated injury is the common pathophysiological mechanism seen in both 
conditions, suggesting that simultaneous occurrence is more than just a coincidence. The 
underlying inflammatory process in both diseases appears to be influenced by cytokines 
such as tumor necrosis factor α (TNF-α) and interleukins including IL-6, IL-8, IL-12 and 
IL-18. HLA genotype links and even infectious agents such as Mycobacterium tuberculosis 
[13] have been implicated as common etiologies, but to date no definite etiological 
associations have been identified.  
Review of published reports of coexisting CD and TA points to CD preceding TA in 
88% of cases in the literature, with the age at diagnosis of CD ranging from 10 to 31 years 
and TA from 14 to 33 years [14]. While age was similar in both of our patients, CD 
preceded TA in one patient, but was diagnosed simultaneously in the other. 
Corticosteroids, immunosuppressive agents and TNF-α inhibition have been effective in 
the management of both CD and TA [15]. However, the current literature does not  
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provide enough information about the management outcomes of this group of patients 
with coexisting diseases. 
In our patients, prednisone was initially started, followed by steroid-sparing agents and 
ultimately biologic therapy. Stenotic and thrombotic complications appear to develop not 
infrequently in this group of patients as evidenced by graft thrombosis and occlusion in 
both of our patients. While our first case had an excellent response to biologic therapy 
and remained asymptomatic, the second case responded poorly to TNF-α therapies and 
was associated with recurrent infectious complications. 
In summary, in these two patients with both CD and TA the diagnoses were confirmed 
by imaging and pathologic findings. Both patients developed vascular complications. 
Cytokine- and interleukin-mediated granulomatous inflammation appears to be the likely 
common pathologic pathway in these two diseases. TNF-α inhibition targeting this 
common pathway was effective in one patient but discontinued in the other due to 
infection. Further research into the association of CD and TA may provide clues to their 
etiologies and guide effective interventions. 
 
 
 
 
 
Fig. 1. Aortic arch angiogram of case 1 showing stenoses of multiple large arteries of the aorta. 
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Fig. 2. Colonoscopy of case 1 showing stricture at the terminal ileum. 
 
 
 
Fig. 3. Angiogram showing stenoses of the right renal artery in case 2. 
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